Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis, J Am Soc Nephrol, vol.27, issue.8, pp.2475-86, 2016. ,
Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis, Nephrol Dial Transplant, vol.22, issue.7, pp.2032-2039, 2007. ,
Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis, N Engl J Med, vol.342, issue.20, pp.1478-83, 2000. ,
Arterial calcifications and bone histomorphometry in end-stage renal disease, J Am Soc Nephrol, vol.15, issue.7, pp.1943-51, 2004. ,
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis, Kidney Int, vol.68, issue.4, p.16164659, 2005. ,
, National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease, Am J KidneyDis, vol.42, pp.1-201, 2003.
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement, Nephrol Dial Transplant, vol.25, issue.12, pp.3823-3854, 2010. ,
, KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD), Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, pp.1-130, 2009.
Executive summary of the 2017 KDIGO chronic Kidney Disease-mineral and bone disorder (CKD-MBD) Guideline update: what's changed and why it matters, Kidney international, vol.92, pp.26-36, 2017. ,
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS), Am J Kidney Dis, vol.52, issue.3, pp.519-549, 2008. ,
The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France, Nephrol Dial Transplant, vol.21, pp.411-418, 2006. ,
URL : https://hal.archives-ouvertes.fr/hal-00452918
Modelling clustered survival data from multicenter clinical trials, Stat Med, vol.23, issue.3, pp.369-88, 2004. ,
Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study, Kidney Int, vol.67, issue.3, pp.1179-87, 2005. ,
Low parathyroid hormone status induced by high dialysate calcium is an independent risk factor for cardiovascular death in hemodialysis patients. French Calcium and Phosphate Observatory, Kidney Int, vol.89, issue.3, pp.666-74, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01850355
Impact of Dialysate Calcium Concentration on Clinical Outcomes in Incident Hemodialysis Patients, Medicine (Baltimore), vol.94, issue.40, p.1694, 2015. ,
The Study of Low Calcium Dialysate on Elderly Hemodialysis Patients with Secondary Hypoparathyroidism, Blood Purif, vol.42, issue.1, pp.3-8, 2016. ,
Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study, Am J Kidney Dis, vol.66, issue.4, pp.655-65, 2015. ,
The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer, Kidney Int, vol.72, issue.10, pp.1255-61, 2007. ,
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study, Am J Kidney Dis, vol.51, issue.6, pp.952-65, 2008. ,
Phosphate-binding agents with CKD: a network meta-analysis of randomized trials, Am j Kidney dis, vol.68, issue.5, pp.691-702, 2016. ,
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. EVOLVE Trial Investigators, N Engl J Med, vol.367, issue.26, pp.2482-94, 2012. ,